Olsen, LR, Mortensen, EL, Bech, P. Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatr Scand
2004; 109: 96–103.
Juruena, MF, Cleare, AJ, Pariante, CM. The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression. Rev Bras Psiquiatr
2004; 26: 189–201.
Bauer, ME, Papadopoulos, A, Poon, L, Perks, P, Lightman, SL, Checkley, S, et al. Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression. Psychiatry Res
2002; 113: 1–15.
Bauer, ME, Papadopoulos, A, Poon, L, Perks, P, Lightman, SL, Checkley, S, et al. Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology
2003; 28: 49–65.
Ribeiro, SC, Tandon, R, Grunhaus, L, Greden, JF. The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry
1993; 150: 1618–29.
Zobel, AW, Yassouridis, A, Frieboes, RM, Holsboer, F. Prediction of medium-term outcome by cortisol response to the combined dexamethasone–CRH test in patients with remitted depression. Am J Psychiatry
1999; 156: 949–51.
Pariante, CM, Papadopoulos, AS, Poon, L, Checkley, SA, English, J, Kerwin, RW, et al. A novel prednisolone suppression test for the hypothalamic–pituitary–adrenal axis. Biol Psychiatry
2002; 51: 922–30.
De Kloet, ER, Vreugdenhil, E, Oitzl, MS, Joels, M. Brain corticosteroid receptor balance in health and disease. Endocr Rev
1998; 19: 269–301.
Juruena, MF, Cleare, AJ, Papadopoulos, AS, Poon, L, Lightman, S, Pariante, CM. Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacol
2006; 189: 225–35.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). APA, 1994.
Beck, AT, Steer, RA, Ball, R, Ranieri, W. Comparison of Beck Depression Inventories –IA and –II in psychiatric outpatients. J Pers Assess
1996; 67: 588–97.
Hamilton, M. A rating scale for depression. J Neuro Neurosurg Psychiatry
1960; 23: 56–62.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM–IV Axis I Disorders – Clinician Version (SCID–CV). American Psychiatric Press, 1997.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. The Structured Clinical Interview for DSM–III–R Personality Disorders (SCID–II).1. Description. J Personal Disord
1995; 9: 83–91.
Sackeim, HA, Prudic, J, Devanand, DP, Decina, P, Kerr, B, Malitz, S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol
1990; 10: 96–104.
Thase, ME, Rush, AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry
1997; 58 (suppl 13): 23–9.
Montgomery, SA, Åsberg, M. A new depression scale designed to be sensitive to change. Br J Psychiatry
1979; 134: 382–9.
Rush, AJ, Gullion, CM, Basco, MR, Jarrett, RB, Trivedi, MH. The Inventory of Depressive Symptomatology (IDS). Psychometric properties. Psychol Med
1996; 26: 477–86.
Beck, AT, Epstein, N, Brown, G, Steer, RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol
1988; 56: 893–7.
Beck, AT, Steer, RA, Ranieri, WF. Scale for Suicide Ideation: psychometric properties of a self-report version. J Clin Psychol
1988; 44: 499–505.
Beck, AT, Weissman, A, Lester, D, Trexler, L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol
1974; 42: 861–5.
Folstein, MF, Folstein, SE, McHugh, PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. JPsychiatric Res
1975; 12: 189–98.
Bosc, M, Dubini, A, Polin, V. Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale. Eur Neuropsychopharmacol
1997; 7 (suppl 1): S57–70.
Rust, J, Bennun, I, Crowe, M, Golombok, S. The construction and validation of the Golombok Rust Inventory of Marital State. Sex Marital Ther
1986; 1: 34–40.
Weissman, AN. The dysfunctional attitude scale. A validation study. Diss Abst Int
1979; 40: 1389–90B.
Buysse, DJ, Reynolds, CF, Monk, TH, Berman, SR, Kupfer, DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res
1989; 28: 193–213.
Rahe, RH. Life change events and mental illness: an overview. J Human Stress
1979; 5: 2–10.
Bifulco, A, Brown, GW, Harris, TO. Childhood Experience of Care and Abuse (CECA): a retrospective interview measure. J Child Psychol Psychiatry
1994; 35: 1419–35.
Bifulco, A, Bernazzani, O, Moran, PM, Jacobs, C. The childhood experience of care and abuse questionnaire (CECA.Q): validation in a community series. Br J Clin Psychol
2005; 44: 563–81.
Taylor, D, Paton, C, Kerwin, R, (eds). The South London and Maudsley NHS Trust Oxleas NHS Trust Prescribing Guidelines (8th edn). Taylor & Francis, 2005.
Gold, PW, Chrousos, GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Mol Psychiatry
2002; 7: 254–75.
Holsboer, F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology
2000; 23: 477–501.
Young, EA, Lopez, JF, Murphy-Weinberg, V, Watson, SJ, Akil, H. Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry
2003; 60: 24–8.
Juruena, MF. The neurobiology of treatment resistant depression: role of the hypothalmic-pituitary-adrenal axis and glucocorticoid and mineralocorticoid receptor function. , University of London, Institute of Psychiatry, 2007.
Kara, S, Yazici, KM, Gulec, C, Unsal, I. Mixed anxiety-depressive disorder and major depressive disorder: comparison of the severity of illness and biological variables. Psychiatry Res
2000; 94: 59–66.
Young, EA, Abelson, JL, Cameron, OG. Effect of comorbid anxiety disorders on the hypothalamic–pituitary–adrenal axis response to a social stressor in major depression. Biol Psychiatry
2004; 56: 113–20.
Ising, M, Horstmann, S, Kloiber, S, Lucae, S, Binder, EB, Kern, N, et al. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression – a potential biomarker?
2007; 62: 47–54.
Beck, AT, Brown, G, Berchick, RJ, Stewart, BL, Steer, RA. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry
1990; 147: 190–5.
Whisman, MA, Kwon, P. Life stress and dysphoria: the role of self-esteem and hopelessness. J Pers Soc Psychol
1993; 65: 1054–60.
Engstrom, G, Alling, C, Gustavsson, P, Oreland, L, Traskman-Bendz, L. Clinical characteristics and biological parameters in temperamental clusters of suicide attempters. J Affect Disord
1997; 44: 45–55.
Jacobs, S, Bruce, M, Kim, K. Adrenal function predicts demoralization after losses. Psychosomatics
1997; 38: 529–34.
Heim, C, Newport, DJ, Wagner, D, Wilcox, MM, Miller, AH, Nemeroff, CB. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety
2002; 15: 117–25.
Nemeroff, CB, Heim, CM, Thase, ME, Klein, DN, Rush, AJ, Schatzberg, AF, et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci USA
2003; 100: 14293–6.
Gervasoni, N, Bertschy, G, Osiek, C, Perret, G, Denis, R, Golaz, J, et al. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode. J Psychiatr Res
2004; 38: 553–7.
Watson, S, Gallagher, P, Del-Estal, D, Hearn, A, Ferrier, IN, Young, AH. Hypothalamic–pituitary–adrenal axis function in patients with chronic depression. Psychol Med
2002; 32: 1021–8.
Kunugi, H, Ida, I, Owashi, T, Kimura, M, Inoue, Y, Nakagawa, S, et al. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic–pituitary–adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study. Neuropsychopharmacology
2006; 31: 212–20.
Kunzel, HE, Binder, EB, Nickel, T, Ising, M, Fuchs, B, Majer, M, et al. Pharmacological and nonpharmacological factors influencing hypothalamic–pituitary–adrenocortical axis reactivity in acutely depressed psychiatric inpatients, measured by the Dex-CRH test. Neuropsychopharmacology
2003; 28: 2169–78.